Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Composition | 61 | 2026 | 267 | 10.110 |
Why?
|
| Milk, Human | 28 | 2026 | 101 | 7.190 |
Why?
|
| Breast Feeding | 27 | 2025 | 99 | 4.200 |
Why?
|
| Child Development | 14 | 2024 | 79 | 3.610 |
Why?
|
| Plethysmography | 20 | 2020 | 27 | 3.570 |
Why?
|
| Weight Gain | 12 | 2026 | 76 | 2.600 |
Why?
|
| Obesity | 25 | 2026 | 699 | 2.430 |
Why?
|
| Adipose Tissue | 21 | 2025 | 195 | 2.380 |
Why?
|
| Infant | 35 | 2026 | 1025 | 2.050 |
Why?
|
| Absorptiometry, Photon | 22 | 2026 | 101 | 1.970 |
Why?
|
| Body Mass Index | 30 | 2025 | 412 | 1.910 |
Why?
|
| Adiposity | 14 | 2024 | 94 | 1.890 |
Why?
|
| Body Weight | 22 | 2019 | 250 | 1.810 |
Why?
|
| Fructose | 5 | 2022 | 22 | 1.670 |
Why?
|
| Infant Nutritional Physiological Phenomena | 6 | 2021 | 40 | 1.650 |
Why?
|
| Female | 87 | 2026 | 15624 | 1.590 |
Why?
|
| Oligosaccharides | 4 | 2026 | 34 | 1.400 |
Why?
|
| Infant, Newborn | 25 | 2026 | 916 | 1.370 |
Why?
|
| Anthropometry | 11 | 2020 | 93 | 1.330 |
Why?
|
| Humans | 107 | 2026 | 28851 | 1.300 |
Why?
|
| Electric Impedance | 10 | 2026 | 31 | 1.240 |
Why?
|
| Leptin | 7 | 2022 | 67 | 1.230 |
Why?
|
| MicroRNAs | 3 | 2022 | 302 | 1.210 |
Why?
|
| Body Water | 12 | 2016 | 19 | 1.190 |
Why?
|
| Diabetes, Gestational | 7 | 2026 | 69 | 1.190 |
Why?
|
| Pregnancy | 23 | 2026 | 1254 | 1.110 |
Why?
|
| Male | 65 | 2026 | 13921 | 1.100 |
Why?
|
| Insulin | 7 | 2021 | 325 | 1.090 |
Why?
|
| Reproducibility of Results | 24 | 2024 | 787 | 1.030 |
Why?
|
| Glucose | 5 | 2021 | 209 | 0.950 |
Why?
|
| Lactation | 9 | 2026 | 76 | 0.940 |
Why?
|
| Interleukin-6 | 4 | 2021 | 198 | 0.940 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 112 | 0.910 |
Why?
|
| Metabolome | 3 | 2024 | 68 | 0.840 |
Why?
|
| Adult | 42 | 2026 | 8024 | 0.840 |
Why?
|
| Pediatric Obesity | 4 | 2021 | 75 | 0.830 |
Why?
|
| Gastrointestinal Microbiome | 4 | 2026 | 138 | 0.790 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 251 | 0.790 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 6 | 2025 | 73 | 0.770 |
Why?
|
| Exosomes | 2 | 2022 | 96 | 0.770 |
Why?
|
| Adipokines | 3 | 2022 | 9 | 0.730 |
Why?
|
| Carbonated Beverages | 2 | 2018 | 3 | 0.710 |
Why?
|
| Hormones | 2 | 2022 | 44 | 0.690 |
Why?
|
| Birth Weight | 5 | 2019 | 63 | 0.650 |
Why?
|
| Body Fluid Compartments | 3 | 2019 | 4 | 0.640 |
Why?
|
| Air | 4 | 2012 | 23 | 0.630 |
Why?
|
| Diet | 5 | 2025 | 241 | 0.630 |
Why?
|
| Overweight | 6 | 2017 | 114 | 0.630 |
Why?
|
| Thiazines | 1 | 2018 | 1 | 0.560 |
Why?
|
| Non-Nutritive Sweeteners | 1 | 2018 | 1 | 0.560 |
Why?
|
| Sucrose | 1 | 2018 | 27 | 0.560 |
Why?
|
| Students | 4 | 2007 | 199 | 0.560 |
Why?
|
| Prospective Studies | 14 | 2024 | 1280 | 0.550 |
Why?
|
| Energy Metabolism | 7 | 2015 | 215 | 0.550 |
Why?
|
| Women's Health | 2 | 2007 | 61 | 0.530 |
Why?
|
| Growth | 2 | 2015 | 24 | 0.510 |
Why?
|
| Mothers | 5 | 2023 | 124 | 0.500 |
Why?
|
| Walking | 2 | 2008 | 136 | 0.490 |
Why?
|
| Athletes | 7 | 2016 | 70 | 0.460 |
Why?
|
| Body Height | 7 | 2018 | 57 | 0.450 |
Why?
|
| Adolescent | 18 | 2016 | 3193 | 0.440 |
Why?
|
| Child | 17 | 2022 | 2287 | 0.430 |
Why?
|
| Models, Biological | 8 | 2025 | 469 | 0.410 |
Why?
|
| Cohort Studies | 9 | 2026 | 897 | 0.410 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2015 | 125 | 0.410 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 841 | 0.380 |
Why?
|
| Martial Arts | 4 | 2012 | 6 | 0.360 |
Why?
|
| Cross-Sectional Studies | 11 | 2018 | 995 | 0.360 |
Why?
|
| Young Adult | 18 | 2025 | 2833 | 0.360 |
Why?
|
| Aging | 6 | 2015 | 1016 | 0.350 |
Why?
|
| Oklahoma | 7 | 2018 | 1052 | 0.330 |
Why?
|
| Monitoring, Physiologic | 2 | 2007 | 58 | 0.330 |
Why?
|
| Exercise | 6 | 2015 | 497 | 0.320 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 377 | 0.320 |
Why?
|
| Reference Values | 6 | 2019 | 200 | 0.310 |
Why?
|
| Dielectric Spectroscopy | 4 | 2012 | 6 | 0.310 |
Why?
|
| Lung Volume Measurements | 2 | 2006 | 4 | 0.310 |
Why?
|
| Gestational Age | 2 | 2019 | 147 | 0.290 |
Why?
|
| Longitudinal Studies | 7 | 2019 | 429 | 0.290 |
Why?
|
| Thorax | 2 | 2007 | 29 | 0.290 |
Why?
|
| United States | 8 | 2026 | 2222 | 0.290 |
Why?
|
| Infant Formula | 2 | 2020 | 18 | 0.290 |
Why?
|
| Sex Characteristics | 4 | 2021 | 173 | 0.280 |
Why?
|
| Physical Exertion | 2 | 2008 | 104 | 0.280 |
Why?
|
| Postpartum Period | 4 | 2025 | 79 | 0.270 |
Why?
|
| Adiponectin | 2 | 2019 | 29 | 0.270 |
Why?
|
| Basal Metabolism | 2 | 2006 | 11 | 0.270 |
Why?
|
| Seasons | 1 | 2007 | 94 | 0.270 |
Why?
|
| Fatty Acids | 2 | 2026 | 218 | 0.260 |
Why?
|
| Holidays | 1 | 2006 | 4 | 0.260 |
Why?
|
| Research Design | 2 | 2024 | 187 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 344 | 0.250 |
Why?
|
| Plethysmography, Whole Body | 2 | 2011 | 2 | 0.250 |
Why?
|
| Linear Models | 5 | 2015 | 202 | 0.240 |
Why?
|
| Age Factors | 5 | 2015 | 737 | 0.240 |
Why?
|
| Milk | 1 | 2026 | 29 | 0.240 |
Why?
|
| Immersion | 1 | 2005 | 4 | 0.240 |
Why?
|
| Universities | 1 | 2006 | 124 | 0.240 |
Why?
|
| Mammary Glands, Animal | 1 | 2026 | 41 | 0.240 |
Why?
|
| Physical Conditioning, Animal | 1 | 2026 | 46 | 0.240 |
Why?
|
| Lipids | 2 | 2022 | 218 | 0.240 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 303 | 0.220 |
Why?
|
| Terminology as Topic | 1 | 2025 | 64 | 0.220 |
Why?
|
| Lipid Metabolism | 1 | 2026 | 150 | 0.220 |
Why?
|
| Hyaluronic Acid | 1 | 2025 | 103 | 0.220 |
Why?
|
| Kynurenine | 1 | 2024 | 22 | 0.220 |
Why?
|
| Cytomegalovirus | 1 | 2024 | 22 | 0.220 |
Why?
|
| Sensitivity and Specificity | 5 | 2016 | 524 | 0.210 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 36 | 0.210 |
Why?
|
| Body Fat Distribution | 4 | 2013 | 15 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2026 | 481 | 0.200 |
Why?
|
| Sports | 2 | 2016 | 25 | 0.200 |
Why?
|
| Oxygen Consumption | 6 | 2013 | 189 | 0.200 |
Why?
|
| Bacteria | 1 | 2025 | 286 | 0.200 |
Why?
|
| Models, Theoretical | 2 | 2013 | 134 | 0.190 |
Why?
|
| Bone Density | 4 | 2022 | 101 | 0.190 |
Why?
|
| Motor Activity | 3 | 2013 | 148 | 0.190 |
Why?
|
| Biomedical Research | 2 | 2013 | 98 | 0.190 |
Why?
|
| Risk Factors | 3 | 2019 | 2126 | 0.180 |
Why?
|
| Sugars | 1 | 2021 | 4 | 0.180 |
Why?
|
| Betaine | 1 | 2021 | 4 | 0.170 |
Why?
|
| Research | 3 | 2024 | 93 | 0.170 |
Why?
|
| Oleic Acids | 1 | 2021 | 4 | 0.170 |
Why?
|
| Middle Aged | 11 | 2019 | 7414 | 0.170 |
Why?
|
| Fruit and Vegetable Juices | 1 | 2020 | 5 | 0.170 |
Why?
|
| Adipose Tissue, Brown | 1 | 2021 | 21 | 0.170 |
Why?
|
| Child, Preschool | 5 | 2020 | 1173 | 0.170 |
Why?
|
| Postprandial Period | 3 | 2025 | 51 | 0.170 |
Why?
|
| Weight Loss | 2 | 2015 | 83 | 0.170 |
Why?
|
| Infant Health | 1 | 2020 | 2 | 0.170 |
Why?
|
| Feces | 3 | 2026 | 116 | 0.160 |
Why?
|
| Body Weights and Measures | 1 | 2020 | 18 | 0.160 |
Why?
|
| Water | 2 | 2015 | 135 | 0.160 |
Why?
|
| Clothing | 1 | 2000 | 4 | 0.160 |
Why?
|
| Muscle, Skeletal | 2 | 2011 | 639 | 0.160 |
Why?
|
| Area Under Curve | 2 | 2018 | 95 | 0.160 |
Why?
|
| Cytokines | 1 | 2022 | 451 | 0.150 |
Why?
|
| Indicator Dilution Techniques | 3 | 2016 | 7 | 0.150 |
Why?
|
| High Fructose Corn Syrup | 1 | 2018 | 1 | 0.140 |
Why?
|
| Isotopes | 2 | 2012 | 10 | 0.140 |
Why?
|
| Random Allocation | 2 | 2015 | 151 | 0.140 |
Why?
|
| Infant, Premature | 1 | 2019 | 149 | 0.140 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 1032 | 0.130 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 94 | 0.130 |
Why?
|
| Cognition | 1 | 2020 | 331 | 0.130 |
Why?
|
| Radioisotope Dilution Technique | 2 | 2009 | 14 | 0.120 |
Why?
|
| Muscle Contraction | 1 | 1997 | 171 | 0.120 |
Why?
|
| Whey Proteins | 1 | 2015 | 13 | 0.120 |
Why?
|
| Pregnancy in Diabetics | 1 | 2015 | 21 | 0.120 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2015 | 36 | 0.120 |
Why?
|
| Pericardium | 1 | 2015 | 47 | 0.120 |
Why?
|
| Nursing Homes | 2 | 1994 | 50 | 0.120 |
Why?
|
| Child of Impaired Parents | 1 | 2015 | 6 | 0.120 |
Why?
|
| Models, Statistical | 2 | 2013 | 128 | 0.120 |
Why?
|
| Echocardiography | 1 | 2015 | 110 | 0.120 |
Why?
|
| Risk | 1 | 2015 | 138 | 0.120 |
Why?
|
| Predictive Value of Tests | 4 | 2013 | 485 | 0.110 |
Why?
|
| Human Development | 1 | 2015 | 4 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2015 | 28 | 0.110 |
Why?
|
| Blood Glucose | 2 | 2019 | 310 | 0.110 |
Why?
|
| Basal Ganglia Diseases | 1 | 1994 | 3 | 0.110 |
Why?
|
| Antipsychotic Agents | 1 | 1994 | 24 | 0.110 |
Why?
|
| Rest | 1 | 2015 | 96 | 0.110 |
Why?
|
| Regression Analysis | 3 | 2005 | 211 | 0.110 |
Why?
|
| Heart Rate | 2 | 2013 | 382 | 0.100 |
Why?
|
| Skinfold Thickness | 2 | 2013 | 19 | 0.100 |
Why?
|
| Accelerometry | 1 | 2013 | 13 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2007 | 997 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2011 | 357 | 0.100 |
Why?
|
| Indians, North American | 2 | 2015 | 544 | 0.100 |
Why?
|
| Torso | 1 | 2013 | 5 | 0.100 |
Why?
|
| Aged | 7 | 2007 | 5598 | 0.100 |
Why?
|
| Muscle Strength | 2 | 2011 | 230 | 0.100 |
Why?
|
| Diet, High-Fat | 2 | 2025 | 144 | 0.100 |
Why?
|
| Drug Utilization | 1 | 1992 | 28 | 0.090 |
Why?
|
| Deuterium | 4 | 2016 | 50 | 0.090 |
Why?
|
| Psychotropic Drugs | 1 | 1992 | 8 | 0.090 |
Why?
|
| Bloodletting | 1 | 1992 | 2 | 0.090 |
Why?
|
| Pulse | 1 | 1992 | 4 | 0.090 |
Why?
|
| African Americans | 3 | 2006 | 352 | 0.090 |
Why?
|
| Posture | 1 | 1992 | 39 | 0.090 |
Why?
|
| Bias | 1 | 2012 | 42 | 0.090 |
Why?
|
| Sex Factors | 2 | 2013 | 467 | 0.090 |
Why?
|
| Forearm | 1 | 2011 | 40 | 0.090 |
Why?
|
| Portugal | 2 | 2012 | 3 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2012 | 391 | 0.090 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2013 | 136 | 0.090 |
Why?
|
| Radial Artery | 1 | 2011 | 21 | 0.090 |
Why?
|
| Apolipoprotein C-III | 1 | 2010 | 12 | 0.080 |
Why?
|
| Algorithms | 2 | 2006 | 431 | 0.080 |
Why?
|
| Software | 1 | 2012 | 127 | 0.080 |
Why?
|
| Glucose Tolerance Test | 2 | 2022 | 60 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2015 | 677 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2012 | 463 | 0.080 |
Why?
|
| Term Birth | 1 | 2009 | 10 | 0.080 |
Why?
|
| Bromides | 3 | 2016 | 5 | 0.080 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2007 | 8 | 0.080 |
Why?
|
| Fetal Blood | 2 | 2022 | 40 | 0.070 |
Why?
|
| Functional Residual Capacity | 2 | 2006 | 2 | 0.070 |
Why?
|
| Hyperlipidemias | 1 | 2008 | 38 | 0.070 |
Why?
|
| Triglycerides | 1 | 2008 | 123 | 0.070 |
Why?
|
| Mass Media | 1 | 2008 | 8 | 0.070 |
Why?
|
| Lipoproteins | 1 | 2008 | 99 | 0.070 |
Why?
|
| Midwestern United States | 1 | 2007 | 40 | 0.070 |
Why?
|
| Thinness | 2 | 2007 | 21 | 0.070 |
Why?
|
| Massachusetts | 2 | 2021 | 18 | 0.070 |
Why?
|
| Gases | 1 | 2007 | 23 | 0.060 |
Why?
|
| Physical Education and Training | 1 | 2007 | 48 | 0.060 |
Why?
|
| Calorimetry, Indirect | 1 | 2006 | 15 | 0.060 |
Why?
|
| Health Status | 1 | 2007 | 149 | 0.060 |
Why?
|
| Waist-Hip Ratio | 1 | 2006 | 9 | 0.060 |
Why?
|
| Alabama | 1 | 2006 | 4 | 0.060 |
Why?
|
| Body Surface Area | 1 | 2006 | 7 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2007 | 106 | 0.060 |
Why?
|
| Bifidobacterium | 1 | 2025 | 3 | 0.060 |
Why?
|
| Health Promotion | 1 | 2008 | 179 | 0.060 |
Why?
|
| Italy | 2 | 2019 | 14 | 0.060 |
Why?
|
| Hydrostatic Pressure | 1 | 2005 | 3 | 0.060 |
Why?
|
| Sarcopenia | 1 | 2026 | 44 | 0.060 |
Why?
|
| Metagenomics | 1 | 2025 | 57 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2026 | 243 | 0.060 |
Why?
|
| Tidal Volume | 1 | 2004 | 6 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2026 | 380 | 0.060 |
Why?
|
| Writing | 1 | 2024 | 14 | 0.060 |
Why?
|
| Science | 1 | 2024 | 18 | 0.060 |
Why?
|
| Research Report | 1 | 2024 | 23 | 0.060 |
Why?
|
| Narration | 1 | 2024 | 20 | 0.050 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2024 | 6 | 0.050 |
Why?
|
| Metabolism | 1 | 2004 | 9 | 0.050 |
Why?
|
| Infusion Pumps | 1 | 2004 | 3 | 0.050 |
Why?
|
| Mentors | 1 | 2024 | 39 | 0.050 |
Why?
|
| Syringes | 1 | 2004 | 8 | 0.050 |
Why?
|
| Viral Load | 1 | 2024 | 32 | 0.050 |
Why?
|
| Publishing | 1 | 2024 | 34 | 0.050 |
Why?
|
| Ethics, Research | 1 | 2024 | 38 | 0.050 |
Why?
|
| Tryptophan | 1 | 2024 | 42 | 0.050 |
Why?
|
| Mice | 2 | 2026 | 4802 | 0.050 |
Why?
|
| Physical Fitness | 2 | 2000 | 62 | 0.050 |
Why?
|
| Homes for the Aged | 2 | 1994 | 7 | 0.050 |
Why?
|
| Animals | 3 | 2026 | 10684 | 0.050 |
Why?
|
| Physical Endurance | 1 | 2003 | 91 | 0.050 |
Why?
|
| C-Peptide | 1 | 2022 | 8 | 0.050 |
Why?
|
| Oxytocin | 1 | 2021 | 6 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2021 | 89 | 0.040 |
Why?
|
| Hair | 1 | 2001 | 15 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 179 | 0.040 |
Why?
|
| Eating | 1 | 2021 | 71 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2026 | 1653 | 0.040 |
Why?
|
| Densitometry | 1 | 2000 | 9 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 1613 | 0.040 |
Why?
|
| Weight Lifting | 1 | 2000 | 49 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 11 | 0.040 |
Why?
|
| Optical Imaging | 1 | 2020 | 35 | 0.040 |
Why?
|
| Ireland | 1 | 2019 | 16 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 222 | 0.040 |
Why?
|
| Breast Milk Expression | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lactose | 1 | 2018 | 6 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 811 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2018 | 138 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 190 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2018 | 80 | 0.030 |
Why?
|
| Ergometry | 1 | 1997 | 7 | 0.030 |
Why?
|
| Acceleration | 1 | 1997 | 17 | 0.030 |
Why?
|
| Neuromuscular Junction | 1 | 1997 | 22 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2015 | 2635 | 0.030 |
Why?
|
| Arm | 1 | 1997 | 37 | 0.030 |
Why?
|
| Motor Skills | 1 | 1997 | 34 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 1997 | 72 | 0.030 |
Why?
|
| Exercise Test | 3 | 2003 | 249 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2016 | 12 | 0.030 |
Why?
|
| Leg | 1 | 1997 | 134 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2016 | 26 | 0.030 |
Why?
|
| Fetal Weight | 1 | 2015 | 8 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 18 | 0.030 |
Why?
|
| Glycated Hemoglobin A | 1 | 2015 | 64 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2015 | 54 | 0.030 |
Why?
|
| Family | 1 | 2015 | 99 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 422 | 0.030 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 1994 | 2 | 0.030 |
Why?
|
| Parkinson Disease, Secondary | 1 | 1994 | 2 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 389 | 0.030 |
Why?
|
| Adolescent Development | 1 | 2013 | 8 | 0.030 |
Why?
|
| Prevalence | 1 | 2015 | 518 | 0.020 |
Why?
|
| Logistic Models | 1 | 1994 | 410 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 402 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 1994 | 249 | 0.020 |
Why?
|
| Geriatric Psychiatry | 1 | 1992 | 1 | 0.020 |
Why?
|
| Education, Nursing, Continuing | 1 | 1992 | 7 | 0.020 |
Why?
|
| Education, Continuing | 1 | 1992 | 11 | 0.020 |
Why?
|
| Mental Processes | 1 | 1992 | 16 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 1992 | 10 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 78 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 1992 | 29 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 1992 | 29 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 1992 | 34 | 0.020 |
Why?
|
| Blood Donors | 1 | 1992 | 4 | 0.020 |
Why?
|
| Diastole | 1 | 1992 | 22 | 0.020 |
Why?
|
| Systole | 1 | 1992 | 24 | 0.020 |
Why?
|
| Extracellular Fluid | 1 | 2011 | 3 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 17 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2011 | 12 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 155 | 0.020 |
Why?
|
| Hand Strength | 1 | 2011 | 39 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 261 | 0.020 |
Why?
|
| Compliance | 1 | 2011 | 21 | 0.020 |
Why?
|
| Puberty | 1 | 2011 | 13 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 274 | 0.020 |
Why?
|
| Sodium Compounds | 1 | 2010 | 2 | 0.020 |
Why?
|
| Body Size | 1 | 2009 | 37 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 1994 | 2065 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 739 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2007 | 10 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 1992 | 2426 | 0.010 |
Why?
|
| Glycerol | 1 | 2004 | 17 | 0.010 |
Why?
|
| Epinephrine | 1 | 2003 | 37 | 0.010 |
Why?
|
| Neoplasms | 1 | 2012 | 874 | 0.010 |
Why?
|
| Scalp | 1 | 2001 | 14 | 0.010 |
Why?
|
| Face | 1 | 2001 | 26 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2000 | 79 | 0.010 |
Why?
|